The One Big Beautiful Bill Act and Cancer Care: What Oncology Leaders Need to Know and Do Now.

Abstract

The One Big Beautiful Bill Act (OBBBA), enacted on July 4, 2025, represents the most substantial restructuring of Medicaid financing since the Balanced Budget Act of 1997. Key provisions include semiannual eligibility redeterminations for expansion adults,implementation of work requirements no later than January 1, 2027, a $35 per-service cost-sharing obligation for adults with incomes between 100% and 138% of the federal poverty level starting in October 2028, and a freeze on provider tax mechanisms. The Congressional Budget Office projects that these measures will result in coverage loss for 11.8 million individuals by 2034. The Congressional Budget Office estimates that the law will increase the number of uninsured people by 10 million in 2034, relative to estimates made before enactment. These policy changes have direct operational consequences for oncology programs. Multicycle cancer therapy necessitates uninterrupted coverage and continuous prior authorization; any lapse may lead to delayed chemotherapy, abandoned treatment protocols, and poorer clinical outcomes. While prior analyses have addressed the epidemiologic and fiscal dimensions of OBBBA, an operational framework for oncology program administrators and managed care decision makers remains absent. This commentary addresses the gap by presenting a framework grounded in peer-reviewed evidence regarding Medicaid work requirement effects, the impact of cost sharing on cancer treatment adherence, and prior authorization burdens in oncology. The proposed framework encompasses 3 operational domains: proactive financial counseling and eligibility infrastructure, payer mix modeling and scenario planning, and prior authorization workflow optimization. Oncology programs that establish these infrastructures during fiscal year 2026 will be better positioned to manage the coverage transition, whereas those that delay may encounter simultaneous challenges related to patient access and financial stability.